Verde Science Stock Analysis
Verde Science is overvalued with Real Value of 6.0E-6 and Hype Value of 1.0E-5. The main objective of Verde Science stock analysis is to determine its intrinsic value, which is an estimate of what Verde Science is worth, separate from its market price. There are two main types of Verde Science's stock analysis: fundamental analysis and technical analysis.
The Verde Science stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Verde Science's ongoing operational relationships across important fundamental and technical indicators.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verde Science. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. Verde Stock Analysis Notes
The company had not issued any dividends in recent years. Verde Science had 1:280 split on the 14th of January 2015. Verde Science, Inc., a pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions. Verde Science, Inc. was founded in 2007 and is based in Dallas, Texas. VERDE SCIENCE operates under Biotechnology classification in the United States and is traded on PNK Exchange. For more information please call Harpreet Sangha at 888-224-6039 or visit https://www.verdescienceinc.com.Verde Science Investment Alerts
| Verde Science generated a negative expected return over the last 90 days | |
| Verde Science has some characteristics of a very speculative penny stock | |
| Verde Science has high likelihood to experience some financial distress in the next 2 years | |
| Verde Science currently holds 32.21 K in liabilities. Verde Science has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Verde Science's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (2.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Verde Science currently holds about 812 in cash with (504.02 K) of positive cash flow from operations. | |
| Verde Science has a frail financial position based on the latest SEC disclosures |
Verde Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 238.Technical Drivers
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Verde Science, as well as the relationship between them.Verde Science Price Movement Analysis
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty with a total number of output elements of fourty-one. The Kaufman Adaptive Moving Average allows the user to define Verde Science range across which they want the smoothing.
Verde Science Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Verde Science insiders, such as employees or executives, is commonly permitted as long as it does not rely on Verde Science's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Verde Science insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Harpreet Sangha over two months ago Acquisition by Harpreet Sangha of 4000000 shares of Verde Science at 0.01 subject to Rule 16b-3 |
Verde Science Outstanding Bonds
Verde Science issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Verde Science uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Verde bonds can be classified according to their maturity, which is the date when Verde Science has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
About Verde Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Verde Science prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Verde shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Verde Science. By using and applying Verde Stock analysis, traders can create a robust methodology for identifying Verde entry and exit points for their positions.
Verde Science, Inc., a pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions. Verde Science, Inc. was founded in 2007 and is based in Dallas, Texas. VERDE SCIENCE operates under Biotechnology classification in the United States and is traded on PNK Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Verde Science to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Complementary Tools for Verde Stock analysis
When running Verde Science's price analysis, check to measure Verde Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verde Science is operating at the current time. Most of Verde Science's value examination focuses on studying past and present price action to predict the probability of Verde Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verde Science's price. Additionally, you may evaluate how the addition of Verde Science to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |